The development of computational methods capable of analyzing -omics data at the
individual level is critical for the success of precision medicine. Although unprecedented …

Objectives Prior research has reported an increased risk of fatality for patients with cancer,
but most studies investigated the risk by comparing cancer to non-cancer patients among …

Objective To introduce a disease prognosis framework enabled by a robust classification
scheme derived from patient-specific transcriptomic response to stimulation. Materials and …

Background Transcriptome analytic tools are commonly used across patient cohorts to
develop drugs and predict clinical outcomes. However, as precision medicine pursues more …

Objectives: To review current studies about designing and implementing clinician-facing
clinical decision support (CDS) integrated or interoperable with an electronic health record (…

Motivation Understanding dynamic, patient-level transcriptomic response to therapy is an
important step forward for precision medicine. However, conventional transcriptome analysis …

In the United States, International Classification of Disease Clinical Modification (ICD-9-CM,
the ninth revision) diagnosis codes are commonly used to identify patient cohorts and to …

The transition of procedure coding from ICD-9-CM-Vol-3 to ICD-10-PCS has generated
problems for the medical community at large resulting from the lack of clarity required to integrate …

Reporting of hospital adverse events relies on Patient Safety Indicators (PSIs) using International
Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM) codes. The …

Background Gene expression profiling has benefited medicine by providing clinically
relevant insights at the molecular candidate and systems levels. However, to adopt a more ‘…